In Februray 2014, 2nd Annual Biologics World Taiwan - the ONLY biologics and biosimilars focused platform in Taiwan - will bring together Taiwanese and international biopharma leaders, innovative biotechs, and technocrats.

2nd Annual Biologics World Taiwan brings to you:

• The most targeted platform to meet Taiwanese and international biologics manufacturers
• Case studies and discussions from senior level decision makers who will influence the direction of Taiwan's biologics industry
• Both strategic and technology-focused biologics development in Taiwan

Key topics include:

• Opportunities and challenges facing Taiwan's Biologics Industry
• Innovation highlights: Biobetters and novel biologics development in Taiwan
• Innovation highlights: Vaccine Development in Taiwan
• Biomanufacturing upstream best practices
• Biomanufacturing downstream best practices
• Operational excellence and PAT
• Crystalballing the future of Taiwan's biologics industry

Key speakers include:

• Dou Chang Lin, Chief Technology Offi­cer, Biologic R&D, Luye Pharma Group
• Karen Wen, President, Mycenax Biotech, Taiwan
• Racho Jordanov, Founder, President and CEO, JHL Biotech
• Yariv Hefez, Vice President of Business Development, Strategy, Portfolio Management and Partnering, Merck Serono
• Dr. Jimmy Zhang, Managing Director, MSD Early Investments
• Dr. Youe-Kong Shue, Vice Chairman, OBO Pharma
• Juine-Ruey Chen, Head of R&D, Adimmune, and many more!